Insider filing · HALO

Nicole LaBrosse sold $1.5M of Halozyme Therapeutics (HALO)

Executed Sep 10 2025, disclosed Sep 11 2025, 1 day later.

Returns are measured on stock purchases only.

NL Nicole LaBrosse SVP, CHIEF FINANCIAL OFFICER profile →

Nicole LaBrosse (SVP, CHIEF FINANCIAL OFFICER) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Halozyme Therapeutics, Inc. (HALO). The largest single filing was $1.5M of HALO (20,000 sh across 2 lots, as filed), executed Sep 10 2025.

HALO Halozyme Therapeutics, Inc. HALO · Healthcare · 38 filings in 24 months ticker →

Healthcare · Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in th…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→